Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products... Show more
AYTU is expected to report earnings to fall 47.79% to -27 cents per share on September 29
Q2'26
Est.
$-0.28
Q1'26
Missed
by $0.32
Q2'25
Missed
by $3.46
Q1'23
Missed
by $1.30
Q4'22
Beat
by $9.45
The last earnings report on May 13 showed earnings per share of -52 cents, missing the estimate of -20 cents. With 7.34K shares outstanding, the current market capitalization sits at 23.72M.